Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1877-1882

  Austgen, Kathryn ^a,b   Oakes, Scott A ^b   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE INHIBITOR; RED FLUORESCENT PROTEIN; REPLICATION AND TRANSCRIPTION ACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL DAMAGE; CELL SURVIVAL; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOST RANGE; HUMAN HERPESVIRUS 8; LATENT PERIOD; MITOCHONDRION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRION; VIROGENESIS; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; APOPTOSIS; CELL LINE; GENES, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; MICE; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8; MURINAE;

EID: 84857099440     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06600-11     Document Type: Article

References (26)

1. Bechtel JT, Liang Y, Hvidding J, Ganem D. 2003. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 77:6474-6481.
2. Blackbourn DJ, et al. 2000. The restricted cellular host range of human herpesvirus 8. AIDS 14:1123-1133.
3. Boshoff C, Weiss RA. 1998. Kaposi's sarcoma-associated herpesvirus. Adv. Cancer Res. 75:57- 86.
4. Cannon ML, Cesarman E. 2004. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene 23:514 -523.
5. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186 -1191.
6. Chandriani S, Ganem D. 2010. Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 84: 5565-5573.
7. Chang H, et al. 2009. Non-human primate model of Kaposi's sarcomaassociated herpesvirus infection. PLoS Pathog. 5:e1000606.
8. Chang Y, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
9. Dittmer D, et al. 1999. Experimental transmission of Kaposi's sarcomaassociated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J. Exp. Med. 190:1857-1868.
10. Du C, Fang M, Li Y, Li L, Wang X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33- 42.
11. Dupin N, et al. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U. S. A. 96:4546-4551.
12. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 1:273-296.
13. Lan K, et al. 2005. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J. Virol. 79:7453-7465.
14. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D. 2002. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16:1977-1989.
15. Liang Y, Ganem D. 2003. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 100:8490-8495.
16. Liang Y, Ganem D. 2004. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J. Virol. 78:6818-6826.
17. Lindsten T, et al. 2000. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6:1389 -1399.
18. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-157.
19. Mutlu AD, et al. 2007. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11:245-258.
20. Oakes SA, Lin SS, Bassik MC. 2006. The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins. Curr. Mol. Med. 6:99 -109.
21. Ojala PM, et al. 1999. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res. 59:4984-4989.
22. Renne R, Blackbourn D, Whitby D, Levy J, Ganem D. 1998. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 72:5182-5188.
23. Spadavecchia S, Gonzalez-Lopez O, Carroll KD, Palmeri D, Lukac DM. 2010. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells. J. Virol. 84:10488 -10500.
24. Susin SA, et al. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441- 446.
25. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325:225-240.
26. Wei MC, et al. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730.